Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Vivian Shi to Dermatitis, Atopic

This is a "connection" page, showing publications Vivian Shi has written about Dermatitis, Atopic.

 
Connection Strength
  
 
 
26.316
  
  1. Rajkumar J, Chandan N, Lio P, Shi V. The Skin Barrier and Moisturization: Function, Disruption, and Mechanisms of Repair. Skin Pharmacol Physiol. 2023; 36(4):174-185.
    View in: PubMed
    Score: 0.799
  2. Shi VY, Chamberlain W, Siegfried E, Kraff-Cooper C, Beckman K, Lio P, Paller AS, Simpson E. Practical management of ocular surface disease in patients with atopic dermatitis, with a focus on conjunctivitis: A review. J Am Acad Dermatol. 2023 08; 89(2):309-315.
    View in: PubMed
    Score: 0.767
  3. Lio P, Mackie D, Bates D, Mulvihill E, Patel M, Kim Y, Shi V. Burden, Control, and Treatment of Moderate to Severe Atopic Dermatitis in 2021: A United States Patient Survey Study. J Drugs Dermatol. 2023 Feb 01; 22(2):119-131.
    View in: PubMed
    Score: 0.765
  4. Thompson AM, Seivright J, Hsiao JL, Shi VY. Bibliometric analysis of the 50 most cited publications in atopic dermatitis. Pediatr Dermatol. 2022 Jul; 39(4):578-583.
    View in: PubMed
    Score: 0.727
  5. Rick JW, Morgan A, De DR, Hsiao JL, Shi VY. Allergens and marketing claims of the most popular baby moisturizers: A product analysis. J Am Acad Dermatol. 2023 01; 88(1):205-207.
    View in: PubMed
    Score: 0.726
  6. Hwang J, Rick J, Hsiao J, Shi VY. A review of IL-36: an emerging therapeutic target for inflammatory dermatoses. J Dermatolog Treat. 2022 Sep; 33(6):2711-2722.
    View in: PubMed
    Score: 0.726
  7. Shi VY, Bhutani T, Fonacier L, Deleuran M, Shumack S, Valdez H, Zhang F, Chan GL, Cameron MC, Yin NC. Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND). J Am Acad Dermatol. 2022 08; 87(2):351-358.
    View in: PubMed
    Score: 0.724
  8. Hwang J, Newton EM, Hsiao J, Shi VY. Aryl hydrocarbon receptor/nuclear factor E2-related factor 2 (AHR/NRF2) signalling: A novel therapeutic target for atopic dermatitis. Exp Dermatol. 2022 04; 31(4):485-497.
    View in: PubMed
    Score: 0.718
  9. Carnicle JM, Hendricks AJ, Shi VY. Reactivation of Alopecia Areata After Dupilumab Therapy for Atopic Dermatitis. Dermatitis. 2021 Oct 01; 32(1S):e80-e82.
    View in: PubMed
    Score: 0.698
  10. Ludwig CM, Hsiao JL, Lio PA, Shi VY. Transitioning From Immunosuppressants to Dupilumab in Pediatric Atopic Dermatitis. Dermatitis. 2021 Oct 01; 32(1S):S4-S7.
    View in: PubMed
    Score: 0.698
  11. Thompson AM, Hsiao JL, Shi VY. National Institutes of Health Funding Trends for Atopic Dermatitis. Dermatitis. 2021 Oct 01; 32(1S):e94-e96.
    View in: PubMed
    Score: 0.698
  12. Hwang J, Thompson A, Jaros J, Blackcloud P, Hsiao J, Shi VY. Updated understanding of Staphylococcus aureus in atopic dermatitis: From virulence factors to commensals and clonal complexes. Exp Dermatol. 2021 10; 30(10):1532-1545.
    View in: PubMed
    Score: 0.689
  13. Rick JW, Alavi A, Hsiao JL, Yosipovitch G, Shi VY. Atopic dermatitis and hidradenitis suppurativa: An under-recognized pair. J Am Acad Dermatol. 2021 12; 85(6):e387-e388.
    View in: PubMed
    Score: 0.685
  14. Ludwig CM, Fernandez JM, Hsiao JL, Shi VY. The Interplay of Atopic Dermatitis and Sexual Health. Dermatitis. 2020 Sep/Oct; 31(5):303-308.
    View in: PubMed
    Score: 0.647
  15. Sachdeva M, Price KN, Hsiao JL, Shi VY. Pearls for Managing Atopic Dermatitis in Patients With Low Socioeconomic Status. Dermatitis. 2020 Sep/Oct; 31(5):297-302.
    View in: PubMed
    Score: 0.647
  16. Jaros J, Wilson C, Shi VY. Fabric Selection in Atopic Dermatitis: An Evidence-Based Review. Am J Clin Dermatol. 2020 Aug; 21(4):467-482.
    View in: PubMed
    Score: 0.644
  17. Hwang J, Jaros J, Shi VY. Staphylococcus aureus in Atopic Dermatitis: Past, Present, and Future. Dermatitis. 2020 Jul/Aug; 31(4):247-258.
    View in: PubMed
    Score: 0.640
  18. Ludwig CM, Krase JM, Price KN, Lio PA, Shi VY. A practical guide for transitioning from classical immunosuppressants to dupilumab in atopic dermatitis. J Dermatolog Treat. 2021 Aug; 32(5):503-506.
    View in: PubMed
    Score: 0.614
  19. Mata E, Loh TY, Ludwig C, Price KN, Fernandez JM, Krase JM, Shi VY. Pharmacy costs of systemic and topical medications for atopic dermatitis. J Dermatolog Treat. 2021 Aug; 32(5):514-516.
    View in: PubMed
    Score: 0.612
  20. Hendricks AJ, Yosipovitch G, Shi VY. Dupilumab use in dermatologic conditions beyond atopic dermatitis - a systematic review. J Dermatolog Treat. 2021 Feb; 32(1):19-28.
    View in: PubMed
    Score: 0.612
  21. Yang EJ, Hendricks AJ, Beck KM, Shi VY. Bioactive: A new era of bioactive ingredients in topical formulations for inflammatory dermatoses. Dermatol Ther. 2019 11; 32(6):e13101.
    View in: PubMed
    Score: 0.609
  22. Hendricks AJ, Manivannan M, Shi VY. Clinical Pearls on Sleep Management in Atopic Dermatitis. Dermatitis. 2019 Sep/Oct; 30(5):287-293.
    View in: PubMed
    Score: 0.604
  23. Hendricks AJ, Lio PA, Shi VY. Management Recommendations for Dupilumab Partial and Non-durable Responders in Atopic Dermatitis. Am J Clin Dermatol. 2019 Aug; 20(4):565-569.
    View in: PubMed
    Score: 0.600
  24. Hendricks AJ, Mills BW, Shi VY. Skin bacterial transplant in atopic dermatitis: Knowns, unknowns and emerging trends. J Dermatol Sci. 2019 Aug; 95(2):56-61.
    View in: PubMed
    Score: 0.597
  25. Heibel HD, Hendricks AJ, Foshee JP, Shi VY. Rosacea associated with dupilumab therapy. J Dermatolog Treat. 2021 Feb; 32(1):114-116.
    View in: PubMed
    Score: 0.594
  26. Hendricks AJ, Shi VY. Learning About Dupilumab-Associated Conjunctivitis. JAMA Dermatol. 2019 06 01; 155(6):754.
    View in: PubMed
    Score: 0.593
  27. Lee GR, Maarouf M, Hendricks AJ, Lee DE, Shi VY. Topical probiotics: the unknowns behind their rising popularity. Dermatol Online J. 2019 May 15; 25(5).
    View in: PubMed
    Score: 0.592
  28. Maarouf M, Hendricks AJ, Shi VY. Bathing Additives for Atopic Dermatitis - A Systematic Review. Dermatitis. 2019 May/Jun; 30(3):191-197.
    View in: PubMed
    Score: 0.590
  29. Vaughn AR, Foolad N, Maarouf M, Tran KA, Shi VY. Micronutrients in Atopic Dermatitis: A Systematic Review. J Altern Complement Med. 2019 Jun; 25(6):567-577.
    View in: PubMed
    Score: 0.586
  30. LePoidevin LM, Lee DE, Shi VY. A comparison of international management guidelines for atopic dermatitis. Pediatr Dermatol. 2019 Jan; 36(1):36-65.
    View in: PubMed
    Score: 0.568
  31. Maarouf M, Kromenacker B, Capozza KL, Kempton D, Hendricks A, Tran K, Shi VY. Pain and Itch Are Dual Burdens in Atopic Dermatitis. Dermatitis. 2018 Sep/Oct; 29(5):278-281.
    View in: PubMed
    Score: 0.564
  32. Maarouf M, Saberian C, Lio PA, Shi VY. Head-and-neck dermatitis: Diagnostic difficulties and management pearls. Pediatr Dermatol. 2018 Nov; 35(6):748-753.
    View in: PubMed
    Score: 0.563
  33. Maarouf M, Shi VY. Bleach for Atopic Dermatitis. Dermatitis. 2018 May/Jun; 29(3):120-126.
    View in: PubMed
    Score: 0.551
  34. Vaughn AR, Clark AK, Sivamani RK, Shi VY. Circadian rhythm in atopic dermatitis-Pathophysiology and implications for chronotherapy. Pediatr Dermatol. 2018 Jan; 35(1):152-157.
    View in: PubMed
    Score: 0.536
  35. Hendricks AJ, Vaughn AR, Clark AK, Yosipovitch G, Shi VY. Sweat mechanisms and dysfunctions in atopic dermatitis. J Dermatol Sci. 2018 Feb; 89(2):105-111.
    View in: PubMed
    Score: 0.534
  36. Lee DE, Clark AK, Tran KA, Shi VY. New and emerging targeted systemic therapies: a new era for atopic dermatitis. J Dermatolog Treat. 2018 Jun; 29(4):364-374.
    View in: PubMed
    Score: 0.528
  37. Vaughn AR, Sivamani RK, Lio PA, Shi VY. Paternal vs. Maternal Factors in Childhood Atopic Dermatitis. Dermatitis. 2017 Jul-Aug; 28(4):241-245.
    View in: PubMed
    Score: 0.520
  38. Shi VY, Leo M, Hassoun L, Chahal DS, Maibach HI, Sivamani RK. Role of sebaceous glands in inflammatory dermatoses. J Am Acad Dermatol. 2015 Nov; 73(5):856-63.
    View in: PubMed
    Score: 0.459
  39. Shi VY, Joo JS, Sharon VR. Multiple labial melanotic macules occurring after topical application of calcineurin inhibitors. Dermatol Online J. 2014 Aug 17; 20(8).
    View in: PubMed
    Score: 0.426
  40. Shi VY, Bao L, Chan LS. Inflammation-driven dermal lymphangiogenesis in atopic dermatitis is associated with CD11b+ macrophage recruitment and VEGF-C up-regulation in the IL-4-transgenic mouse model. Microcirculation. 2012 Oct; 19(7):567-79.
    View in: PubMed
    Score: 0.374
  41. Stein Gold LF, Tom WL, Shi V, Sanders P, Zang C, Vlahos B, Cha A. Impact of Crisaborole in Treatment-Experienced Patients With Mild-to-Moderate Atopic Dermatitis. Dermatitis. 2024 Jan-Feb; 35(1):84-91.
    View in: PubMed
    Score: 0.204
  42. Worm M, Thyssen JP, Schliemann S, Bauer A, Shi VY, Ehst B, Tillmann S, Korn S, Resen K, Agner T. The pan-JAK inhibitor delgocitinib in a cream formulation demonstrates dose response in chronic hand eczema in a 16-week randomized phase IIb trial. Br J Dermatol. 2022 07; 187(1):42-51.
    View in: PubMed
    Score: 0.181
  43. Modiri O, Yee D, Shi VY, Hsiao JL. Readability, Quality, and Timeliness of Online Health Resources for Atopic Dermatitis. Dermatitis. 2021 Oct 01; 32(1S):e89-e91.
    View in: PubMed
    Score: 0.174
  44. Chandan N, Rajkumar JR, Shi VY, Lio PA. A new era of moisturizers. J Cosmet Dermatol. 2021 Aug; 20(8):2425-2430.
    View in: PubMed
    Score: 0.170
  45. Shah M, Sachdeva M, Alavi A, Shi VY, Hsiao JL. Optimizing care for atopic dermatitis patients during the COVID-19 pandemic. J Am Acad Dermatol. 2020 08; 83(2):e165-e167.
    View in: PubMed
    Score: 0.158
  46. Capozza K, Gadd H, Kelley K, Russell S, Shi V, Schwartz A. Insights From Caregivers on the Impact of Pediatric Atopic Dermatitis on Families: "I'm Tired, Overwhelmed, and Feel Like I'm Failing as a Mother". Dermatitis. 2020 May/Jun; 31(3):223-227.
    View in: PubMed
    Score: 0.158
  47. Jaros J, Hendricks AJ, Shi VY, Lio PA. A Practical Approach to Recalcitrant Face and Neck Dermatitis in Atopic Dermatitis. Dermatitis. 2020 May-Jun; 31(3):169-177.
    View in: PubMed
    Score: 0.158
  48. Costello C, Maarouf M, Shi V. Navigating Targeted Therapeutics in Dermatology: Biologics and Small Molecules J Drugs Dermatol. 2018 12 01; 17(12):1330-1332.
    View in: PubMed
    Score: 0.143
  49. Bao L, Shi VY, Chan LS. IL-4 up-regulates epidermal chemotactic, angiogenic, and pro-inflammatory genes and down-regulates antimicrobial genes in vivo and in vitro: relevant in the pathogenesis of atopic dermatitis. Cytokine. 2013 Feb; 61(2):419-25.
    View in: PubMed
    Score: 0.095
  50. Bao L, Alexander JB, Shi VY, Mohan GC, Chan LS. Interleukin-4 up-regulation of epidermal interleukin-19 expression in keratinocytes involves the binding of signal transducer and activator of transcription 6 (Stat6) to the imperfect Stat6 sites. Immunology. 2014 Dec; 143(4):601-8.
    View in: PubMed
    Score: 0.027
  51. Bao L, Shi VY, Chan LS. IL-4 regulates chemokine CCL26 in keratinocytes through the Jak1, 2/Stat6 signal transduction pathway: Implication for atopic dermatitis. Mol Immunol. 2012 Feb; 50(1-2):91-7.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.